title: Autoimmune-like hepatitis following unrelated BMT successfully treated with rituximab.
authors.forename: A
authors.initials: A
authors.lastname: Narita
authors.forename: H
authors.initials: H
authors.lastname: Muramatsu
authors.forename: Y
authors.initials: Y
authors.lastname: Takahashi
authors.forename: H
authors.initials: H
authors.lastname: Sakaguchi
authors.forename: S
authors.initials: S
authors.lastname: Doisaki
authors.forename: N
authors.initials: N
authors.lastname: Nishio
authors.forename: A
authors.initials: A
authors.lastname: Hama
authors.forename: A
authors.initials: A
authors.lastname: Shimada
authors.forename: M
authors.initials: M
authors.lastname: Ito
authors.forename: S
authors.initials: S
authors.lastname: Kojima
mesh_terms: D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D005260:Female; D019693:Hepatitis, Autoimmune / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D000069283:Rituximab; D014184:Transplantation, Homologous; D061349:Unrelated Donors
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab